Khyber Medical University to Conduct Clinical Trials for New Leishmaniasis Drug
Khyber Medical University (KMU) has finalized arrangements for conducting clinical trials of a new indigenously developed drug for leishmaniasis, marking a significant step forward in medical research and treatment options for the disease.
Khyber Medical University to Initiate Clinical Trials for Novel Herbal Leishmaniasis Treatment
• Khyber Medical University (KMU) is set to begin clinical trials for a locally developed herbal medicine targeting cutaneous leishmaniasis (CL).
• The six-month trial will assess the herbal ointment's effectiveness against CL in comparison to glucantime injections and photodynamic therapy (PDT).
• The trials will take place in a CL hotspot, likely the Malakand district, to include patients from Bajaur and Mohmand districts, areas with high CL incidence.
© Copyright 2025. All Rights Reserved by MedPath